PW Medtech Group Limited (1358.HK): Deep Value Arbitrage Amidst a Structural Pivot to Hemodialysis
1. Executive Summary Investment Thesis: A Fortress Balance Sheet with a Free Call Option on Growth PW Medtech Group Limited (“PW Medtech” or the “Group”) currently presents one of the most pronounced dislocations between intrinsic asset value and market capitalization within the Hong Kong healthcare small-cap sector. Trading at a market capitalization of HK$ 1.975 … Read more